Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers

INTRODUCTION: Endocrine therapy of breast cancer, which either deprives cancer tissue of estrogen or prevents estrogen pathway signaling, is the most common treatment after surgery and radiotherapy. We have previously shown for the estrogen-responsive MCF-7 cell line that exposure to tamoxifen, or d...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Euphemia Y., Askarian-Amiri, Marjan E., Sarkar, Debina, Ferraro-Peyret, Carole, Joseph, Wayne R., Finlay, Graeme J., Baguley, Bruce C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591432/
https://www.ncbi.nlm.nih.gov/pubmed/28929082
http://dx.doi.org/10.3389/fonc.2017.00184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591432/
https://www.ncbi.nlm.nih.gov/pubmed/28929082
http://dx.doi.org/10.3389/fonc.2017.00184

Ejemplares similares